Strax Q3 2022: Steps in the right direction

Research Update

2022-11-28

07:30

Management continues to execute according to its action list, having divested two brands plus its licensing business in Q3. It aims to sell its Health & Wellness business in the coming two to four months. Having cut revenues and EBIT by around 7%, Redeye adjust Base Case only marginally to SEK2.9.

FR

JVK

Fredrik Reuterhäll

Jesper Von Koch

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.